Treatment of allergic rhinitis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 2, 514 12, 514 21, A61K 3764

Patent

active

051661349

ABSTRACT:
A method for the prophylaxis or direct treatment of allergic rhinitis which comprises nasally administering to a patient an effective amount of a serine protease inhibitor which inhibits mast cells, neutrophiles or T-cells or binds with their mediators.

REFERENCES:
patent: 4636489 (1987-01-01), Seemuller et al.
patent: 4732973 (1988-03-01), Barr et al.
patent: 4857314 (1989-08-01), O'Connor et al.
patent: 4916117 (1990-04-01), Lezdey et al.
patent: 5008242 (1991-04-01), Lezdey et al.
Hubbard et al, Biochemical Efficacy and Safety of Monthly Augmentation Therapy for Alpha 1-Antitrypsin Deficiency-Sep. 2, 1988-vol. 260, No. 9.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of allergic rhinitis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of allergic rhinitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of allergic rhinitis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-921706

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.